Cas:13762-95-3 (2H4)Hydrazine manufacturer & supplier

We serve Chemical Name:(2H4)Hydrazine CAS:13762-95-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2H4)Hydrazine

Chemical Name:(2H4)Hydrazine
CAS.NO:13762-95-3
Synonyms:(H)Hydrazine;tris-pentadeuteriophenyl-phosphane;deuterated hydrazine hydrate;triphenylphosphine-d15;Hydrazine-d
Molecular Formula:D4N2
Molecular Weight:36.070
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:113.5±9.0 °C at 760 mmHg
Density:0.9±0.1 g/cm3
Index of Refraction:1.422
PSA:52.04000
Exact Mass:36.062553
LogP:-1.20

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (H)Hydrazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Hydrazine-d physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tris-pentadeuteriophenyl-phosphane Use and application,(H)Hydrazine technical grade,usp/ep/jp grade.


Related News: A number of UK citizens had trouble reaching the muster point in time for the first flight out because of road blocks and other restrictions in place in Wuhan. (2H4)Hydrazine manufacturer Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. (2H4)Hydrazine supplier He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines. (2H4)Hydrazine vendor The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. (2H4)Hydrazine factory Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report.